Figures & data
Figure 1 Incidences of symptomatic thromboembolic events and treatment-emergent major bleeding events by timing of first dose of prophylactic therapy.
Abbreviations: EMA, European Medicines Agency; SOC, standard of care.
![Figure 1 Incidences of symptomatic thromboembolic events and treatment-emergent major bleeding events by timing of first dose of prophylactic therapy.](/cms/asset/71fccddd-44db-4926-8b19-742fc98b1b14/dvhr_a_100293_f0001_c.jpg)
Figure 2 Incidences of events by timing of first dose of thromboprophylaxis.
Abbreviations: CI, confidence interval; EMA, European Medicines Agency; OR, odds ratio; SOC, standard of care.
![Figure 2 Incidences of events by timing of first dose of thromboprophylaxis.](/cms/asset/789c66e0-b178-48e0-a9dd-32f22e3c5f5a/dvhr_a_100293_f0002_b.jpg)
Figure 4 Incidences of events by type of anesthesia.
Abbreviations: CI, confidence interval; EMA, European Medicines Agency; OR, odds ratio; SOC, standard of care.
![Figure 4 Incidences of events by type of anesthesia.](/cms/asset/9d4bad81-915a-474c-9cbd-f0ef4782adeb/dvhr_a_100293_f0004_b.jpg)
Table 1 Incidence of symptomatic thromboembolic events by type of surgery and anesthesia
Figure 5 Incidences of symptomatic thromboembolic events in patients receiving rivaroxaban or SOC with and without the use of mechanical thromboprophylaxis.
Abbreviation: SOC, standard of care.
![Figure 5 Incidences of symptomatic thromboembolic events in patients receiving rivaroxaban or SOC with and without the use of mechanical thromboprophylaxis.](/cms/asset/10c606d1-ac56-44ac-b803-5b0e6959905f/dvhr_a_100293_f0005_c.jpg)